Why Shares of Protagonist Therapeutics Rose This Week
What happened
Shares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company’s stock closed last week at $18.74 and rose to as high as $23.74
Shares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company’s stock closed last week at $18.74 and rose to as high as $23.74